Kimihiro Okubo

Title: Kimihiro Okubo: Innovator in Antigen Exposure Technology

Introduction

Kimihiro Okubo is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of antigen exposure technology, holding a total of 3 patents. His work focuses on improving the efficiency and effectiveness of antigen supply and exposure systems.

Latest Patents

Okubo's latest patents include an innovative antigen supply device. This device is primarily designed with a cylindrical member that extends vertically. It features an air suction port at the lower end to draw air into the antigen exposure chamber. An axial fan is positioned above the air suction port to create an upward airflow. Additionally, a supply port allows high-concentration antigens to be jetted from a dust feeder outside the chamber. This design enables the mixing of antigens with air, ensuring a uniform distribution of the antigen mixture within the exposure chamber.

Another significant patent is the antigen exposure chamber system. This system addresses the limitations of conventional antigen exposure chambers. It allows for the simultaneous exposure of multiple test objects to a uniform antigen, such as pollen or house dust, throughout the year. The system incorporates an outdoor air diffuser in the ceiling, which supplies air horizontally into the chamber. It also includes a fan unit in each corner to circulate air, ensuring a consistent concentration of antigens.

Career Highlights

Throughout his career, Okubo has worked with reputable organizations, including Shinryo Corporation and the Tokyo Metropolitan Institute of Medical Science. His experience in these institutions has contributed to his expertise in developing advanced antigen exposure technologies.

Collaborations

Okubo has collaborated with notable colleagues, including Huaipeng Tang and Akihiro Seta. These partnerships have further enhanced his research and development efforts in the field.

Conclusion

Kimihiro Okubo's innovative work in antigen exposure technology has led to significant advancements in the field. His patents reflect a commitment to improving the efficiency of antigen supply and exposure systems. His contributions continue to impact research and applications in this important area.